Lifevantage Profit Margin 2006-2019 | LFVN

Current and historical gross margin, operating margin and net profit margin for Lifevantage (LFVN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Lifevantage net profit margin as of September 30, 2019 is 3.65%.
Lifevantage Annual Profit Margins
Lifevantage Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.213B $0.226B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.506B 22.32
McKesson (MCK) United States $25.635B 10.16
Align Technology (ALGN) United States $21.730B 59.55
AmerisourceBergen (ABC) United States $18.171B 12.46
Laboratory Of America Holdings (LH) United States $16.670B 15.65
Cardinal Health (CAH) United States $16.049B 10.43
Straumann Holding AG (SAUHF) Switzerland $15.257B 0.00
Cooper (COO) United States $15.229B 24.87
DENTSPLY SIRONA (XRAY) United States $12.911B 25.24
West Pharmaceutical Services (WST) United States $10.911B 46.82
Henry Schein (HSIC) United States $10.187B 18.97
CONMED (CNMD) United States $3.236B 45.97
Patterson (PDCO) United States $2.250B 16.67
STAAR Surgical (STAA) United States $1.662B 86.79
Merit Medical Systems (MMSI) United States $1.609B 18.80
Atrion (ATRI) United States $1.310B 36.09
Antares Pharma (ATRS) United States $0.798B 489.00
Invacare (IVC) United States $0.310B 0.00
Pro-Dex (PDEX) United States $0.063B 17.07
Endologix (ELGX) United States $0.042B 0.00
Biolase (BIOL) United States $0.016B 0.00